本页面由Tiger Trade Technology Pte. Ltd.提供服务

TFF Pharmaceuticals

0.0650
0.0000
成交量:- -
成交额:- -
市值:28.88万
市盈率:-0.01
高:0.0650
开:0.0650
低:0.0650
收:0.0650
52周最高:0.0650
52周最低:0.0650
股本:444.30万
流通股本:324.24万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.7837
每股收益(LYR):-11.8508
净资产收益率:-220.13%
总资产收益率:-106.45%
市净率:0.09
市盈率(LYR):-0.01

数据加载中...

2024/05/08

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/03

SEC问询函

Form CORRESP - Correspondence
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/27

SEC问询函

Form CORRESP - Correspondence
2024/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/08

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/16

重要事件披露

Form 8-K - Current report
2023/12/09

SEC问询函

Form CORRESP - Correspondence
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/05

重要事件披露

Form 8-K - Current report